[go: up one dir, main page]

NO981594L - Behandling av infeksjoner forÕrsaket av Helicobacter pylori - Google Patents

Behandling av infeksjoner forÕrsaket av Helicobacter pylori

Info

Publication number
NO981594L
NO981594L NO981594A NO981594A NO981594L NO 981594 L NO981594 L NO 981594L NO 981594 A NO981594 A NO 981594A NO 981594 A NO981594 A NO 981594A NO 981594 L NO981594 L NO 981594L
Authority
NO
Norway
Prior art keywords
treatment
helicobacter pylori
infections caused
pylori
methods
Prior art date
Application number
NO981594A
Other languages
English (en)
Other versions
NO981594D0 (no
Inventor
Bow Ho
Original Assignee
Cortecs International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9520585.2A external-priority patent/GB9520585D0/en
Application filed by Cortecs International Ltd filed Critical Cortecs International Ltd
Publication of NO981594D0 publication Critical patent/NO981594D0/no
Publication of NO981594L publication Critical patent/NO981594L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nye fremgansmåter for behandling av H. pylori-infeksjoner, så vel som farmasøytiske preparater for anvendelse ved slike fremgangsmåter. Preparatene for konverteringen av spiralformen av H. pylori omfatter urease.
NO981594A 1995-10-09 1998-04-07 Behandling av infeksjoner forÕrsaket av Helicobacter pylori NO981594L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9520585.2A GB9520585D0 (en) 1995-10-09 1995-10-09 Therapeutic method
US1588296P 1996-04-19 1996-04-19
PCT/GB1996/002456 WO1997013527A1 (en) 1995-10-09 1996-10-08 Treatments of helicobacter pylori infections

Publications (2)

Publication Number Publication Date
NO981594D0 NO981594D0 (no) 1998-04-07
NO981594L true NO981594L (no) 1998-06-03

Family

ID=26307915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981594A NO981594L (no) 1995-10-09 1998-04-07 Behandling av infeksjoner forÕrsaket av Helicobacter pylori

Country Status (9)

Country Link
EP (1) EP0862458A1 (no)
JP (1) JPH11514998A (no)
KR (1) KR19990064104A (no)
CN (1) CN1201395A (no)
AU (1) AU7141096A (no)
BR (1) BR9611033A (no)
MX (1) MX9802809A (no)
NO (1) NO981594L (no)
WO (1) WO1997013527A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101558150A (zh) * 2006-11-14 2009-10-14 根特大学 螺杆菌的体外培养
US7939079B2 (en) 2006-11-14 2011-05-10 Universiteit Gent Helicobacter species and cultivation thereof
JP5145700B2 (ja) * 2006-11-20 2013-02-20 学校法人慶應義塾 キャリア

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection

Also Published As

Publication number Publication date
EP0862458A1 (en) 1998-09-09
KR19990064104A (ko) 1999-07-26
AU7141096A (en) 1997-04-30
CN1201395A (zh) 1998-12-09
BR9611033A (pt) 1999-12-28
WO1997013527A1 (en) 1997-04-17
JPH11514998A (ja) 1999-12-21
MX9802809A (es) 1998-11-29
NO981594D0 (no) 1998-04-07

Similar Documents

Publication Publication Date Title
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
BR0109703A (pt) Derivados de piperazina
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
MA26435A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant.
EA200101075A1 (ru) Новый способ лечения
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
NO982874L (no) Farmasöytiske preparater med vitamin D-analoger
NO983530L (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
NO972449L (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
NO981594L (no) Behandling av infeksjoner forÕrsaket av Helicobacter pylori
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
NO975682L (no) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
DE69007651D1 (de) 5-Carbamoylthieno(2,3-B)thiophen-2-sulfonamide als topisch aktive Kohlensäureanhydraseinhibitoren.
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi